Jesus Ching

Chief Technology Officer & Co-Founder

BIOTECHNOLOGY BIOTECHNOLOGY EXPERT BUSINESS EXPERT CELL AND MOLECULAR BIOLOGY EXPERT COMPUTER ENGINEERING EXPERT DATA SCIENCE EXPERT ENTREPRENEUR ENTREPRENEURSHIP EXPERT FOUNDER GENETICS EXPERT HEALTHCARE EXPERT HEALTH EXPERT HEART HEALTH EXPERT MEDICAL RESEARCH EXPERT MENOPAUSE MENOPAUSE EXPERT NEUROSCIENTIST PREVENTATIVE MEDICINE SCIENCE EXPERT STARTUPS STARTUPS EXPERT STEM EXPERT TECH EXPERT TECHNOLOGY EXPERT VENTURE CAPITAL WELLNESS EXPERT WOMEN'S HEALTH EXPERT
YEARS ACTIVE 2022–Present
CERTIFICATIONS
  • PhD

ABOUT

Jesus Ching is a scientist, inventor, and entrepreneur with over 30 years of experience and

more than 50 patents spanning molecular diagnostics, genomics, proteomics, and

CRISPR-based technologies. A true pioneer in next-generation diagnostics, Jesus has built a

career transforming scientific innovation into clinically impactful, commercially successful

products.

He has founded multiple diagnostics companies, three of which were acquired by industry

leaders Bio-Rad, Luminex/DiaSorin, and Cepheid/Danaher. His deep technical

expertise—combined with a relentless focus on first-principles thinking—has led to the creation

and launch of numerous products across point-of-care, lab-based, and multi-omic testing

platforms that redefine what’s possible in human diagnostics.

At Xella Health, Jesus leads the company’s scientific and technological vision, applying his

decades of experience in molecular systems design to power Xella’s AI- and multi-omic-based

precision health platform for women. Jesus holds a PhD in Chemistry from Baylor University and

a BS in Biology and Chemistry from Houston Baptist University.

ASSOCIATED BRANDS

HEADSHOTS

Download all